Cargando…

Hemoadsorption therapy in the critically ill: solid base but clinical haze

Detalles Bibliográficos
Autores principales:	Honoré, Patrick M., De Bels, David, Barreto Gutierrez, Leonel, Spapen, Herbert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355888/ https://www.ncbi.nlm.nih.gov/pubmed/30706173 http://dx.doi.org/10.1186/s13613-019-0491-1

Ejemplares similares

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Heparin-binding protein in sepsis: player! predictor! positioning?
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
por: Honore, Patrick M., et al.
Publicado: (2019)

Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
por: Honore, Patrick M., et al.
Publicado: (2018)

Normal saline as resuscitation fluid in critically ill patients: not dead yet!
por: Honore, Patrick M., et al.
Publicado: (2016)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

What should be the best dialysis catheter lock in critically ill patients?
por: Honore, Patrick M., et al.
Publicado: (2019)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

A Double Catheter Approach for Extracorporeal CO(2) Removal Integrated Within a Continuous Renal Replacement Circuit
por: Bels, David De, et al.
Publicado: (2018)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
por: Honore, Patrick M., et al.
Publicado: (2020)

Hemoadsorption efficacy for uncomplicated high-risk cardiac surgery
por: Redant, Sébastien, et al.
Publicado: (2019)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Hemoadsorption in Critical Care – It is a Useful or a Harmful Technique?
por: Kovacs, Judit
Publicado: (2020)

Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

New generation indirect calorimeters for measuring energy expenditure in the critically ill: a rampant or reticent revolution?
por: De Waele, Elisabeth, et al.
Publicado: (2016)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Hemoadsorption in LVAD Surgery: Suitable in Theory?
por: Ozturk, Mahmut, et al.
Publicado: (2023)

Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
por: Honore, Patrick M., et al.
Publicado: (2020)

Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
por: Honore, Patrick M., et al.
Publicado: (2016)

Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
por: Chen, Xiukai, et al.
Publicado: (2018)

Hemoadsorption in critically ill patients with or without COVID-19: A word of caution
por: Putzu, Alessandro, et al.
Publicado: (2021)

Dexmedetomidine: the first new kid on the block for preventing cardiac surgery-associated acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2018)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
por: Chang, Kaixi, et al.
Publicado: (2023)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
por: Honore, Patrick M., et al.
Publicado: (2020)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
por: Honore, Patrick M., et al.
Publicado: (2020)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Validity of the relationship between mobility group box-1 protein and poor post–cardiac arrest neurological outcome during renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qirb2mun1doj9leem1qdlhtte1